Treatments of Parkinson's disease
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Department of pharmacology | hu_HU |
| dc.contributor.author | Abukhalid, Nouf Hassan | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2019-09-24T12:51:56Z | |
| dc.date.available | 2019-09-24T12:51:56Z | |
| dc.date.created | 2018-10-05 | |
| dc.description.abstract | Parkinson’s disease is a progressive neurodegenerative disorder, A combination of environmental factors or toxins, genetic susceptibility, and the ageing process or Secondary forms of Parkinsonism can happen with medications. for treatment it involve Neuroprotection, Symptom Management, Early-Stage and late-stage Treatment. | hu_HU |
| dc.description.corrector | LB | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 55 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/273705 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Parkinson's disease | hu_HU |
| dc.subject | neurodegenerative disease | hu_HU |
| dc.subject | dopaminergic neuron degeneration | hu_HU |
| dc.subject | Carbidopa/levodopa | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Treatments of Parkinson's disease | hu_HU |